We are live on ! Find out more
KFS

Kurt F. Somerville Portfolio holdings

AUM $379M
1-Year Est. Return 19.42%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+19.42%
3 Year Est. Return
+62.7%
5 Year Est. Return
+83.65%
10 Year Est. Return
+302.17%
AUM
$257M
AUM Growth
+$5.27M
Cap. Flow
-$6.61M
Cap. Flow %
-2.58%
Top 10 Hldgs %
36.95%
Holding
105
New
4
Increased
18
Reduced
53
Closed
2

Top Buys

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$635K
2
XYL icon
Xylem
XYL
+$508K
3
GSK icon
GSK
GSK
+$464K
4
TGT icon
Target
TGT
+$358K
5
QCOM icon
Qualcomm
QCOM
+$332K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$2.79M
2
PEP icon
PepsiCo
PEP
+$2.28M
3
LH icon
Labcorp
LH
+$1.2M
4
XOM icon
ExxonMobil
XOM
+$451K
5
DE icon
Deere & Co
DE
+$294K

Sector Composition

Rank Sector Weight
1 Healthcare 22.63%
2 Technology 22.38%
3 Industrials 19%
4 Energy 13.93%
5 Consumer Staples 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TTE icon
76
TotalEnergies
TTE
$188B
$404K 0.16%
5,598
– –
ALNY icon
77
Alnylam Pharmaceuticals
ALNY
$37.6B
$400K 0.16%
6,317
-475
-7% -$28.2K
SU icon
78
Suncor Energy
SU
$76.1B
$384K 0.15%
9,000
– –
WFC icon
79
Wells Fargo
WFC
$266B
$363K 0.14%
6,900
– –
DD icon
80
DuPont de Nemours
DD
$18.8B
$343K 0.13%
2,635
+128
+5% +$16.3K
IONS icon
81
Ionis Pharmaceuticals
IONS
$9.4B
$342K 0.13%
+9,960
New +$314K
SYY icon
82
Sysco
SYY
$39.9B
$322K 0.13%
8,600
– –
JPM icon
83
JPMorgan Chase
JPM
$950B
$311K 0.12%
5,400
– –
SRCL
84
DELISTED
Stericycle Inc
SRCL
$296K 0.12%
2,500
– –
TXN icon
85
Texas Instruments
TXN
$258B
$287K 0.11%
6,000
– –
INTU icon
86
Intuit
INTU
$83B
$280K 0.11%
3,475
-125
-3% -$9.64K
IVV icon
87
iShares Core S&P 500 ETF
IVV
$872B
$275K 0.11%
1,398
– –
VZ icon
88
Verizon
VZ
$197B
$263K 0.1%
5,380
-231
-4% -$11.2K
MFC icon
89
Manulife Financial
MFC
$73.2B
$255K 0.1%
12,788
– –
PSX icon
90
Phillips 66
PSX
$82.7B
$253K 0.1%
3,139
– –
XEC
91
DELISTED
CIMAREX ENERGY CO
XEC
$243K 0.09%
1,694
– –
TEVA icon
92
Teva Pharmaceuticals
TEVA
$36.1B
$236K 0.09%
4,500
-10
-0.2% -$511
HUB.B
93
DELISTED
HUBBELL INC CL-B
HUB.B
$236K 0.09%
1,914
-18
-0.9% -$2.13K
EXPD icon
94
Expeditors International
EXPD
$22.6B
$228K 0.09%
5,157
-2,119
-29% -$91.1K
PCL
95
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$215K 0.08%
4,770
– –
COL
96
DELISTED
Rockwell Collins
COL
$210K 0.08%
2,685
– –
IDXX icon
97
Idexx Laboratories
IDXX
$44.4B
$200K 0.08%
+3,000
New +$191K
DHR icon
98
Danaher
DHR
$134B
$197K 0.08%
+3,720
New +$191K
GEVO icon
99
Gevo
GEVO
$392M
$9K ﹤0.01%
2
– –
AMGN icon
100
Amgen
AMGN
$205B
– –
-1,636
Closed -$201K
1 2 3
4

Similar funds

NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
CFG
Carr Financial Group Worcester, Massachusetts $379M AUM 21.34% 1-Year Est. Return
MLFP
MPS Loria Financial Planners Burr Ridge, Illinois $379M AUM 17.57% 1-Year Est. Return
CSWG
Cardinal Strategic Wealth Guidance Louisville, Kentucky $379M AUM 19.59% 1-Year Est. Return
RWA
Rooted Wealth Advisors Bourbonnais, Illinois $379M AUM 13.75% 1-Year Est. Return
EAM
Empirical Asset Management Wellesley, Massachusetts $379M AUM 24.52% 1-Year Est. Return
PIM
Progressive Investment Management Lake Oswego, Oregon $379M AUM 24.17% 1-Year Est. Return
AC
Attestor Capital Grand Cayman, Cayman Islands $380M AUM

Kurt F. Somerville's Q2 2014 Portfolio in Review

As of Q2 2014, Kurt F. Somerville held 105 positions worth $257M, up 2.1% from $251M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Kurt F. Somerville's Q2 2014 filing shows 4 new, 18 increased, 53 reduced and 2 closed positions. Its largest new stake was Xylem: 13,600 shares worth $530K. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $2.79M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.

  • Kurt F. Somerville's largest Q2 2014 buy was Xylem: 13,600 shares worth $530K.
  • Kurt F. Somerville added most to Xilinx Inc in Q2 2014, an estimated $635K increase.
  • Kurt F. Somerville's biggest Q2 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $2.79M.
  • Kurt F. Somerville fully exited Amgen in Q2 2014, selling an estimated $201K.
  • Kurt F. Somerville's ten largest holdings make up 37% of its $257M portfolio in Q2 2014.
  • Kurt F. Somerville opened 4 new positions and closed 2 in Q2 2014.
  • Kurt F. Somerville's portfolio value rose 2.1% quarter-over-quarter to $257M.

Based on Kurt F. Somerville's 13F filing for Q2 2014, filed 23 Jul 2014.